Yohann L.
- Country
- France
- Department
- Département d’Innovation Thérapeutique et des Essais Précoces
Research Overview
- Phase 1 Open-Label Multicenter Study of INCA033890 in Patients with Advanced or Metastatic Solid Tumors
- Phase 1 Study of AMX-818 Monotherapy and Combination with Pembrolizumab in Advanced or Metastatic HER2-Expressing Cancers
- Evaluation of [Main Substance] in Combination with Other Agents in Patients with Advanced Solid Tumors
Data & Insights
Has run more than one trial at 248 of 455 partner sites.
Specializations
Oncology Focus
This investigator specializes in the study of advanced and metastatic solid tumors, contributing to the development of innovative therapeutic approaches in clinical oncology.
- Solid Tumor Treatment
- Advanced Cancer Therapy
- Metastatic Disease Management
The research encompasses therapeutic interventions for patients with progressive solid malignancies.
Treatment Development
The investigator's work centers on evaluating novel therapeutic agents for solid tumor treatment, with particular attention to advanced stage cancers.
- Novel Therapeutic Approaches
- Clinical Investigation
- Treatment Innovation
Their research activities focus on exploring new treatment options for patients with limited therapeutic alternatives.
Clinical Expertise
Specializing in advanced oncology, the investigator conducts research in treating complex cases of solid tumors requiring specialized therapeutic intervention.
- Advanced Disease Management
- Therapeutic Assessment
- Clinical Evaluation
The research focuses on addressing the needs of patients with progressive malignancies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.